Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on January 10, 2008

Arteriosclerosis, Thrombosis, and Vascular Biology. 2008
Published online before print January 10, 2008, doi: 10.1161/ATVBAHA.107.159889
A more recent version of this article appeared on April 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow Additional Materials
Right arrow All Versions of this Article:
28/4/725    most recent
ATVBAHA.107.159889v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, P.
Right arrow Articles by Zhang, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, P.
Right arrow Articles by Zhang, Y.

Submitted on July 17, 2007
Accepted on December 31, 2007

Cross-Talk Among Smad, MAPK, and Integrin Signaling Pathways Enhances Adventitial Fibroblast Functions Activated by Transforming Growth Factor–{beta}1 and Inhibited by Gax

Ping Liu ; Cheng Zhang ; Jin Bo Feng ; Yu Xia Zhao ; Xu Ping Wang ; Jian Min Yang ; Ming Xiang Zhang ; Xing Li Wang ; and Yun Zhang *

From the Key Laboratory of Cardiovascular Remodeling and Function Research (P.L., C.Z., J.B.F., Y.X.Z., X.P.W., J.M.Y., M.X.Z., Y.Z.), Chinese Ministry of Education and Chinese Ministry of Health, Shandong University Qilu Hospital, Jinan, Shandong, China; the Second Hospital of Shandong University (P.L.), Jinan, Shandong, China; and the Texas Heart Institute at St Luke’s Episcopal Hospital (X.L.W.), Division of Cardiothoracic Surgery, Michael DeBakey Department of Surgery, Baylor College of Medicine, Houston, Tex.

* To whom correspondence should be addressed. E-mail: zhangyun{at}sdu.edu.cn.

Objective—We investigated whether Smad, mitogen-activated protein kinase (MAPK), and integrin signaling pathways cross-talk to enhance adventitial fibroblast (AF) bioactivity, which was activated by transforming growth factor (TGF)-{beta}1 and inhibited by Gax.

Methods and Results—Cultured AFs were stimulated with Ad-Gax, TGF-{beta}1, and siRNA-Gax. Assays for AFs viabilities demonstrated that TGF-{beta}1 and siRNA-Gax enhanced AFs proliferative, migratory, and adherent abilities, whereas Gax counteracted TGF-{beta}1–activated actions. Flow cytometry revealed that TGF-{beta}1 and siRNA-Gax increased S phase cells; however, Gax decreased AFs in the S phase and increased those in the G0-G1 and apoptotic phases. RT-PCR, Western blotting, and immunocytochemistry showed that TGF-{beta}1 and siRNA-Gax upregulated the expression of cytokines in Smad, MAPK, and integrin signaling pathways, and downregulated that of p15, p16, and p21. Conversely, Gax induced downregulation of these cytokines and upregulation of p15, p16, and p21. Thus, these signaling pathways cross-talk to enhance AF bioactivity; Gax effectively counteracts TGF-{beta}1 effects, blocks the cross-talk of these pathways, inhibits AF functions, and increases AF apoptosis.

Conclusions—Our findings indicate that cross-talk among Smad, MAPK, and integrin signaling pathways may account mainly for the mechanism of AF functions. Gax is a promising therapeutic gene for dissecting the signaling pathways controlling AF bioactivities.


Key words: adventitial fibroblast • signaling pathway • cell function • TGF-{beta}1 • Gax